Onchocerciasis and Lymphatic Filariasis

Parasitic Infections and the Immune System

Volumn , Issue , 2013, Pages 225-247

  Williams, Jeffrey F ^a   Mackenzie, Charles D ^b   ElKhalifa, Mohammed ^c  

^a Department of Microbiology Michigan State University ^*  (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0040531933     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-092405-2.50012-6     Document Type: Chapter

References (100)

1. Abraham D., Grieve R.B. Active and passive immunization of mice against larvae of Dirofilaria immitis. J. Parasitol 1988, 74:275-282.
2. Ackerman S.J., Kephart G.M., Francis H., Awadzi K., Gleich G.J., Ottesen E.A. Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis. J. Immunol. 1990, 144:3961-3969.
3. Bartlett A., Turk J., Ngu J., Mackenzie C., Fuglsang H., Anderson J. Variation in delayed hypersensitivity in onchocerciasis. Trans. R. Soc. Trop. Med. Hyg. 1978, 72:372.
4. Boyer A.E., Tsang V.C., Eberhard M.L., Zea-Flores G., Hightower A., Pilcher J.B., Zea-Flores R., Zhou W., Reimer C.B. Guatemalan human onchocerciasis. II. Evidence for IgG3 involvement in acquired immunity to Onchocerca volvulus and identification of possible immune-associated antigens. J. Immunol. 1991, 146:4001-4010.
5. Brattig N.W., Tischendorf F.W., Albiez E.J., Buttner D.W., Berger J. Distribution pattern of peripheral lymphocyte subsets in localised and generalised forms of onchocerciasis. Clin. Immunol. Immunopathol. 1987, 44:149-159.
6. Campbell W.C. Ivermectin as an antiparasitic agent for use in humans. Annu. Rev. Microbiol. 1991, 45P:445-474.
7. Carlow C.K.S., Bianoc A.E. Transfer of immunity to the microfilariae of Onchocerca lienalis in mice. Trop. Med. Parasitol. 1987, 38:236-283.
8. Cartel J.L., Spiegel A., Nguyen L., Plichart R., Martin P.M., Roux J.F. Traitement de la microfilaremie a Wuchereria bancrofti var. pacifica: Ivermectine versus diethylcarbamazine. Ann. Soc. Belge. Med. Trop. 1991, 71:229-236.
9. Cesbron J.Y., Capron A., Vargaftig B.B., Legarde M., Pincemail J., Braquet P., Taelman H., Joseph M. Platelets mediate the action of diethylcarbamazine on microfilariae. Nature (London) 1987, 325:533-536.
10. Cesbron J.Y., Hayasaki M., Joseph M., Lutsch C., Grzych J.M., Capron A. Monoclonal anti-idiotype antibody as antigen signal for the microfilaricidal cytotoxicity of diethylcarbamazine-treated platelets. J. Immunol. 1988, 141:279-285.
11. Chan C.C., Nussenblatt R.B., Kim M.K., Palestine A.G., Awadzi K., Ottesen E.A. Immunopathology of ocular onchocerciasis. 2. Anti-retinal autoantibodies in serum and ocular fluids. Ophthalmology 1987, 94:439-443.
12. Colina K.F., Perler F.B., Matsumura I., Meda M., Nutman T.B. The identification of an Onchocerca-specific recombinant antigen containing a T-cell epitope. J. Immunol. 1990, 145:1551-1556.
13. Cookson E., Blaxter M.L., Selkirk M.E. Identification of the major soluble cuticular glycoprotein of lymphatic filarial nematode parasites (gp29) as a secretory homolog of glutathione peroxidase. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:5837-5841.
14. Cupp E.W. Treatment of onchocerciasis with ivermectin in Central America. Parasitol. Today 1992, 8:212-214.
15. Dadzie K.Y., Remme J., De Sole G. Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus. Trans. R. Soc. Trop. Med. Hyg. 1991, 85:267-271.
16. Dafa'Alla T.H., Ghalib H.W., Abelmageed A., Williams J.F. The profile of IgG and IgG subclasses of onchocerciasis patients. Clin. Exp. Immunol. 1992, 88:258-263.
17. Duke B.O. Observations and reflections on the immature stages of Onchocerca volvulus in the human host. Ann. Trop. Med. Parasitol. 1991, 85:103-110.
18. Egwang T.G., Kazura J.W. The BALB/c mouse as a model for immunological studies of microfilariae-induced pulmonary eosinophilia. Am. J. Trop. Med. Hyg. 1990, 43:61-66.
19. ElKhalifa, M. Y. (1989). Cellular and humoral immune responses in onchocerciasis: Correlations with clinical signs and infection intensity. Ph.D. Thesis, Michigan State University, East Lansing.
20. ElKhalifa M.Y., Ghalib H.W., Dafa'Alla T., Williams J.F. Suppression of human lymphocyte responses to specific and non-specific stimuli in human onchocerciasis. Clin. Exp. Immunol. 1991, 86:433-439.
21. Erttman K.D., Unnasch T.R., Greene B.M., Albiez E.J., Boateng J., Denke A.M., Ferraroni J.J., Karam M., Schultz-Key H., Williams P.N. A DNA sequence specific for forest form of Onchocerca volvulus. Nature (London) 1987, 327:415-417.
22. Fassler P.E., Tranquilli W.J., Paul A.J., Soll M.D., DiPietro J.A., Todd K.S. Evaluation of the safety of ivermectin administered in a beef-based formulation to ivermectin-sensitive collies. J. Am. Vet. Med. Assoc. 1991, 199:457-460.
23. Foster C.B., Flanigan T.P., Kazura J.W., Dumenco L.L., Ratnoff O.D. Inhibition of the activation of Hageman factor (factor XII) and of platelet aggregation by extracts of Brugia malayi microfilariae. J. Lab. Clin. Med. 1991, 117:344-352.
24. Freedman D.O., Lujan-Trangay A., Steel C., Gonzalez-Peralta C., Nutman T.B. Immunoregulation in onchocerciasis. Functional and phenotypic abnormalities of lymphocyte subsets and changes with therapy. J. Clin. Invest. 1991, 88:231-238.
25. Gallin M., Edmonds K., Ellner J.J., Erttmann K.D., Whiter A.T., Newland H.S., Taylor H.R., Greene B.M. Cell-mediated immune responses in human infections with Onchocerca volvulus. J. Immunol. 1988, 140:1999-2007.
26. Garate T., Kliks M.M., Cabrera A., Parkhouse R.M. Specific and cross-reacting antibodies in human responses to Onchocerca volvulus and Dracunculus medinensis infections. Am. J. Trop. Med. Hyg. 1990, 42:140-147.
27. Ghalib H., Mackenzie C.D., Williams J.F., Sisley B.M., Elkhalifa M.Y. Immunology and the development of pathology in onchocerciasis: Studies in Sudan. Sudan Med. J. 1985, 21:59-64.
28. Ghalib H.W., Mackenzie C.D., Kron M.A., Williams J.F., Elkhalifa M., ElSheikh H. Severe onchocercal dermatitis in the Ethiopian border region of Sudan. Ann. Trop. Med. Parasitol. 1987, 81:405-419.
29. Greene B., Fanning M., Ellner J. Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus infection in man. Clin. Exp. Immunol. 1983, 52:259-265.
30. Greene B.M., Gbakima A.A., Albiez E.J., Taylor H.R. Humoral and cellular immune responses to Onchocerca volvulus infection in humans. Rev. Infect. Dis. 1985, 7:789-795.
31. Grieve R.B., Abraham D., Mika-Grieve M., Seibert B.P. Induction of protective immunity in dogs to infection with Dirofilaria immitis with chemically abbreviated infections. Am. J. Trop. Med. Hyg. 1988, 39:373-379.
32. Guderian R.H., Anselmi M., Beck B.J., Mackenzie C.D., Williams J.F., Proano J.R., Cooper P.J. The effect of antimalarial chloroquine therapy and prophylaxis on concurrent infection with Onchocerca volvulus in Ecuador. Trans. R. Soc. Trop. Med. Hyg. 1991, 85:634-638.
33. Hamann K.J., Gleich G.J., Checkel J.L., Loegering D.A., McCall J.W., Barker R.L. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins. J. Immunol. 1990, 144:3166-3173.
34. Hammerberg B., Nogami S., Nakagaki K., Hayashi Y., Tanaka H. Protective immunity against Brugia malayi infective larvae in mice. II. Induction by a T cell-dependent antigen isolated by monoclonal antibody affinity chromatography and SDS-PAGE. J. Immunol. 1989, 143:4201-4207.
35. Haque A., Capron A., Quaissi A., Kouemeni L., Lejeune J., Bonnel B., Pierce R. Immune unresponsiveness and its possible relation to filarial disease. Contr. Microbiol. Immunol. 1983, 7:9-16.
36. Hayashi Y., Nakagaki K., Nogami S., Hammerberg B., Tanaka H. Protective immunity against Brugia malayi infective larvae in mice. I. Parameters of active and passive immunity. Am. J. Trop. Med. Hyg. 1989, 41:650-656.
37. Henkle K.J., Liebau E., Muller S., Bergmann B., Walter R.D. Characterization and molecular cloning of a Cu/Zn superoxide dismutase from the human parasite Onchocerca volvulus. Infect. Immun. 1991, 59:2063-2069.
38. Hitch W.L., Lammie P.J., Walker E.M., Hightower A.W., Eberhard M.L. Antifilarial cellular responses detected in a Haitian pediatric population by use of a microblastogenesis assay. J. Infect. Dis. 1991, 164:811-813.
39. Hussain R., Ottesen E.A. IgE responses in human filariasis. III. Specificities of IgE and IgG antibodies compared by immunoblot analysis. J. Immunol. 1985, 135:1415-1420.
40. Hussain R., Ottesen E.A. IgE responses in human filariasis. IV. Parallel recognition by IgE and IgG4 subclass antibodies. J. Immunol. 1986, 136:1859-1863.
41. Johnson P.J., Mackenzie C.D., Denham D.A., Suswillo R.R. The effect of diethylcarbamazine on the in vitro serum mediated adherence of feline granulocytes to microfilariae of Brugia pahangi. Trop. Med. Parasitol. 1988, 39:291-294.
42. Kaiser L., Lamb V.L., Tithof P.K., Gage D.A., Chamberlain B.A., Watson J.T., Williams J.F. Dirofilaria immitis: Do filarial cyclooxygenase products depress endothelial dependent relaxation in the in vitro rat aorta?. Exp. Parasitol. 1992, 75:159-167.
43. Kazura J.W., Maroney P.A., Pearlman E., Nilsen T.W. Protective efficacy of a cloned Brugia malayi antigen in a mouse model of microfilaremia. J. Immunol. 1990, 145:2260-2264.
44. Klei T.R., Blanchard D.P., Coleman S.U. Development of Brugia pahangi infections and lymphatic lesions in male offspring of female jirds with homologous infections. Trans. R. Soc. Trop. Med. Hyg. 1986, 80:214-216.
45. Kwan-Lim G.E., Maizels R.M. MHC and non-MHC-restricted recognition of filarial surface antigens in mice transplanted with adult Brugia malayi parasites. J. Immunol. 1990, 145:1912-1920.
46. Lal R.B., Kumaraswami V., Steel C., Nutman T.B. Phosphocholine-containing antigens of Brugia malayi nonspecifically suppress lymphocyte function. Am. J. Trop. Med. Hyg. 1990, 42:56-64.
47. Lammie P.J., Hitch W.L., Walker Allen E.M., Hightower W., Eberhard M.L. Maternal filarial infection as risk factor for infection in children. Lancet 1991, 1:1005-1006.
48. Lee S.J., Francis H.L., Awadzi K., Ottesen E.A., Nutman T.B. Changes in antibody profile after treatment of human onchocerciasis. J. Infect. Dis. 1990, 162:529-533.
49. Leichsenring M., Troger J., Nelle M., Buttner D.W., Darge K., Doehring-Schwerdtfeger E. Ultrasonographical investigations of onchocerciasis in Liberia. Am. J. Trop. Med. Hyg. 1990, 43:380-385.
50. Limaye A.P., Abrams J.S., Silver J.E., Awadzi K., Francis H.F., Ottesen E.A., Nutman T.B. Interleukin-5 and the posttreatment eosinophilia in patients with onchocerciasis. J. Clin. Invest. 1991, 88:1418-1421.
51. Liu L.X., Serhan C.N., Weller P.F. Intravascular filarial parasites elaborate cyclooxygenase-derived eicosanoids. J. Exp. Med. 1990, 172:993-996.
52. 2 by microfilariae of Wuchereria bancrofti and Brugia malayi. Am. J. Trop. Med. Hyg. 1992, 46:520-523.
53. Lobos E., Weiss N., Karam M., Taylor H.R., Ottesen E.A., Nutman T.B. An immunogenic Onchocerca volvulus antigen: A specific and early marker of infection. Science 1991, 251:1603-1605.
54. McCauliffe D.P., Zappi E., Lieu T.S., Michalak M., Sontheimer R.D., Capra J.D. A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule.". J. Clin. Invest. 1990, 86:332-335.
55. Mackenzie C.D. Eosinophil leucocytes in filarial infections. Trans. R. Soc. Trop. Med. Hyg. 1980, 74:51-58.
56. Mackenzie C.D. Immune responses in onchocerciasis and dracunculiasis. "Immune Response in Parasitic Infections: Immunology, Immunopathology, and Immunoprophylaxis" 1986, 1:181-232. CRC Press, Boca Raton, Florida. E.J.L. Soulsby (Ed.).
57. Mackenzie C.D., Kron M.A. Diethylcarbamazine: A review of its action in onchocerciasis, lymphatic filariasis and inflammation. Trop. Dis. Bull. 1985, 82:R1-R37.
58. Mackenzie C.D., Williams J.F. Variations in the clinical presentation of onchocerciasis and their relationship to the host-parasite interaction. Sudan Med. J. 1985, 21:41-48.
59. Mackenzie C.D., Williams J.F., Sisley B.M., Steward M.W., O'Day J. Variations in host responses and the pathogenesis of human onchocerciasis. Rev. Infect. Dis. 1985, 7:802-808.
60. Mackenzie C.D., Williams J.F., Guderian R.H. Clinical responses in human onchocerciasis: Parasitological and immunological implications. Ciba. Found. Symp. 1986, 127:46-67.
61. Mackenzie C.D., Williams J.F., O'Day J., Ghalal I., Flockhart H.A., Sisley B.M. Onchocerciasis in southwestern Sudan: Parasitological and clinical charactersitics. Am. J. Trop. Med. Hyg. 1987, 36:371-382.
62. Miller S., Schreuer D., Hammerberg B. Inhibition of antigen-driven proliferative responses and enhancement of antibody production during infection with Brugia pahangi. J. Immunol. 1991, 147:1007-1013.
63. Murdoch M.E., Hay R.J., Mackenzie C.D., Williams J.F., Ghalib H.W., Cousens S., Abiose A., Jones B.R. A clinical classification and grading system of the cutaneous changes in onchocerciasis. Br. J. Dermatol. 1993, (in press).
64. Nanduri J., Kazura J.W. Paramyosin-enhanced clearance of Brugia malayi microfilaremia in mice. J. Immunol. 1989, 143:3359-3363.
65. Nutman T.B., Vijayan V.K., Pinkston P., Kumaraswami V., Steel C., Crystal R.G., Ottesen E.A. Tropical pulmonary eosinophilia: Analysis of antifilarial antibody localized to the lung. J. Infect. Dis. 1989, 160:1042-1050.
66. Nutman T.B., Steel C., Ward D.J., Zea-Flores G., Ottesen E.A. Immunity to onchocerciasis: Recognition of larval antigens by humans putatively immune to Onchocerca volvulus infection. J. Infect. Dis. 1991, 163:1128-1133.
67. O'Day J., Mackenzie C.D., Williams J.F. Ocular changes in patients infected with the filarial nematode Onchocerca volvulus in southwestern Sudan. Aust. J. Ophthalmol. 1984, 12:211-217.
68. Ottesen E.A. Immediate hypersensitivity responses in the immunopathogenesis of human onchocerciasis. Rev. Infect. Dis. 1985, 7:796-801.
69. Ottesen E.A. Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans. Rev. Infect. Dis. 1985, 7:341-356.
70. Ottesen E.A., Kumaraswami V., Paranjape R., Poindexter R.W., Tripathy S.P. Naturally occurring blocking antibodies modulate immediate hypersensitivity responses in human filariasis. J. Immunol. 1981, 127:2014-2020.
71. Ottesen E.A., Skvaril F., Tripathy S.P., Pointdexter R.W., Hussain R. Prominence of IgG4 in the IgG antibody response to human filariasis. J. Immunol. 1985, 134:2707-2712.
72. Ottesen E.A., Vijayasekaran V., Kumaraswami V., Perumal Pillai S.V., Sadanandam A., Frederick S., Prabhakar R., Tripathy S.P. A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis. N. Engl. J. Med. 1990, 322:1113-1117.
73. Pearson C.A. A major cause of Third World rheumatism largely overlooked-Onchocerciasis. Br. J. Rheumatol. 1988, 27:414-415.
74. Perez-Rojas G.E., Valderrama M., Anderson C., Machado I., Bianco N., Yarzabal L. Inmunidad mediada por celulas en la oncocercosis:modificaciones por factores sericos. Filariasis Humans Territorio Fed. Amazonas 1983, 2:93-102.
75. Piessens W.F., Mackenzie C.D. Immunology of lymphatic filariasis and onchocerciasis. "Immunology of Parasitic Infections" 1982, 622-653. Black-well, Cambridge, Massachusetts. K. Warren (Ed.).
76. Piessens W., Ratiwayanto S., Titi S., Palmieri J., Piessens P., Koiman I., Dennis D. Antigen-specific suppressor cells and suppressor factors in human filariasis with Brugia malayi. N. Engl. J. Med. 1980, 302:833-837.
77. Piessens W., Partono F., Hoffman S., Ratiwayanto S., Piessens P., Palmieri J., Koiman I., Dennis D., Carney W. Antigen-specific suppressor T-lymphocytes in human lymphatic filariasis. N. Engl. J. Med. 1982, 307:144-149.
78. Prost A., Nebout M., Rougemont A. Lepromatous leprosy and onchocerciasis. Br. Med. J. 1979, 1:589-590.
79. Rajan T.V., Nelson F.K., Cupp E., Schultz L.D., Greiner D.L. Survival of Onchocerca volvulus in nodules implanted in immunodeficient rodents. J. Parasitol. 1992, 78:160-163.
80. Ravindran B., Satapathy A.K., Pattnaik N.M. Antibodies to diethylcarbamazine cross-react with microfilariae of Wuchereria bancrofti. Immunol. Lett. 1988, 17:7-11.
81. Rothova A., Van der Lelij A., Stilma J.S., Wilson W.R., Barbe R.F. Side-effects of ivermectin in treatment of onchocerciasis. Lancet 1989, 1:1439-1441.
82. Rothova A., Van der Lelij A., Stilma J.S., Klaassen-Broekema N., Wilson W.R., Barbe R.F. Ocular involvement in patients with onchocerciasis after repeated treatment with ivermectin. Am. J. Ophthalmol. 1990, 110:6-16.
83. Rougemont A., Boisson-Pontal M., Pontal P., Gridel F. Tuberculin skin tests and B.C.G. vaccination in hyperendemic area of onchocerciasis. Lancet 1977, 1:309.
84. Selkirk M.E., Rutherford P.J., Bianco A.E., Flint J.E., Denham D.A., Paratono F., Maizels R.M. Characterization and cloning of lymphatic filarial antigens. Mol. Paradigms. Erad. Helminthic Parasites, Proc. UpJohn-UCLA Symp. 1987, 1:169-181.
85. Snowden K., Hammerberg B. Dynamics of immune responses related to clinical status in Brugia pahangi-infected dogs. Am. J. Trop. Med. Hyg. 1987, 37:143-151.
86. Soboslay P.T., Dreweck C.M., Taylor H.R., Brotman B., Wenk P., Greene B.M. Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production of effects of IL-1 and IL-2 with Onchocerca volvulus infection. J. Immunol. 1991, 147:346-353.
87. Soboslay P.T., Dreweck C.M., Hoffmann W.H., Luder C.G.K., Hueschkel C., Gorgen H., Banla M., Schulz-Key H. Ivermectin-facilitated immunity in onchocerciasis: Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment. Clin. Exp. Immunol. 1992, 89:407-413.
88. Steel C., Lujan-Trangay A., Gonzalez-Peralta C., Zea-Flores G., Nutman T.B. Immunologic responses to repeated ivermectin treatment in patients with onchocerciasis. J. Infect. Dis. 1991, 164:581-587.
89. Titanji V.P.K., Monebenimp F., Ngu J.L. Serum immunoglobulin E levels in onchocerciasis: The development of a radioallergosorbent test for Onchocerca volvulus infection. Trop. Parasitol. 1985, 36:12-16.
90. Tsang V.C., Boyer A.E., Pilcher J.B., Eberhard M.L., Reimer C.B., Zea-Flores G., Zea-Flores R., Zhou W., Richards F.O. Guatemalan human onchocerciasis. I. Systematic analysis of patient populations, nodular antigens, and specific isotypic reactions. J. Immunol. 1991, 146:3993-4000.
91. Unnasch T.R., Gallin M.Y., Soboslay P.T., Erttmann K.D., Greene B.M. Isolation and characterization of expression cDNA clones encoding antigens of Onchocerca volvulus infective larvae. J. Clin. Invest. 1988, 82:262-269.
92. Wadee A.A., Vickery A.C., Piessens W.F. Characterization of immunosuppressive proteins of Brugia malayi microfilariae. Acta Trop. 1987, 44:343-352.
93. Ward D.J., Nutman T.B., Zea-Flores G., Portocanero C., Lujan jA., Ottesen E.A. Onchocerciasis and immunity in humans; enhanced T-cell responsiveness to parasite antigen in putatively immune individuals. J. Infect. Dis. 1988, 157:536-543.
94. Weil G.J., Ogunrinade A.F., Chandrashekar R., Kale O.O. IgG4 subclass antibody serology for onchocerciasis. J. Infect. Dis. 1990, 161:549-554.
95. Weiss N., Spiesen F., Hussain R. Antibodies in human onchocerciasis. Application of a newly developed radioallergosorbent test (RAST). Acta Trop. 1981, 38:353-362.
96. Whitworth J.A.G., Morgan D., Maude G.H., Luty A.J.F., Taylor D.W. A community trial of ivermectin for onchocerciasis in Sierra Leone: Clinical and parasitological responses to four doses given at six-monthly intervals. Trans. R. Soc. Trop. Med. Hyg. 1991, 86:277-280.
97. Williams J.F., Mackenzie C.D., ElKhalifa M., Ghalib H.W. Immunological features of onchocerciasis in Sudan. J. Commun. Dis. 1986, 18:301-307.
98. Williams J.F., Ghalib H.W., Mackenzie C.D., ElKhalifa M.Y., Ayuya J.M., Kron M.A. Cell adherence to microfilariae of Onchocerca volvulus: A comparative study. Ciba Found. Symp. 1987, 1:146-158.
99. Yates J.A., Higashi G.I. Brugia malayi: Vaccination of jirds with 60 cobalt-attenuated infective stage larvae protects against homologous challenge. Am. J. Trop. Med. Hyg. 1985, 34:1132-1137.
100. Yates J.A., Higashi G.I., Lowichik A., Orihel T.C., Lowrie R.C., Eberhard M.L. Activation of the alternative complement pathway in normal human serum by Loa loa and Brugia malayi infective stage larvae. Acta Trop. 1985, 42:157-163.